Halton, J., & Brückmann, M. (2017). Phase IIa study of dabigatran etexilate in children with venous thrombosis: Pharmacokinetics, safety, and tolerability. Journal of thrombosis and haemostasis, 15(11), . https://doi.org/10.1111/jth.13847
Chicago Style (17th ed.) CitationHalton, Jacqueline, and Martina Brückmann. "Phase IIa Study of Dabigatran Etexilate in Children with Venous Thrombosis: Pharmacokinetics, Safety, and Tolerability." Journal of Thrombosis and Haemostasis 15, no. 11 (2017). https://doi.org/10.1111/jth.13847.
MLA (9th ed.) CitationHalton, Jacqueline, and Martina Brückmann. "Phase IIa Study of Dabigatran Etexilate in Children with Venous Thrombosis: Pharmacokinetics, Safety, and Tolerability." Journal of Thrombosis and Haemostasis, vol. 15, no. 11, 2017, https://doi.org/10.1111/jth.13847.